Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × daromun × Clear all

Phase

Status

Unknown 2 Recruiting 2 Not yet recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 448 Carboplatin 323 Nivolumab 301 Cyclophosphamide 291 Cisplatin 253 Specimen Handling 249 Paclitaxel 248 Magnetic Resonance Spectroscopy 244 Radiotherapy 220 Gemcitabine 185 Dexamethasone 181 Biopsy 173 durvalumab 172 atezolizumab 154 Doxorubicin 140 Rituximab 134 Lenalidomide 134 Docetaxel 132 Ipilimumab 131 Bevacizumab 129 Radiation 121 Capecitabine 120 Oxaliplatin 118 Etoposide 118 Fluorouracil 115 Radiosurgery 114 Pemetrexed 110 fludarabine 106 venetoclax 102 Prednisone 100

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02938299 2024-09-19

Pivotal

Philogen S.p.A.

Phase 3 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡